INTERFERON-β TREATMENT IS EFFECTIVE FOR CHRONIC HEPATITIS C PATIENTS WITH ANTI-INTERFERON-α NEUTRALIZING ANTIBODIES

被引：0
|
作者：
Kuga, Chisa [1 ]
Matsuda, Fuko [1 ]
Torii, Yuichi [1 ]
Enomoto, Hirayuki [1 ]
Aizawa, Nobuhiro [1 ]
Tanaka, Hironori [1 ]
Iwata, Yoshinori [1 ]
Saito, Masaki [1 ]
Imanishi, Hiroyasu [1 ]
Shimomura, Soji [1 ]
Nakamura, Hideji [1 ]
Tsutsui, Hiroko [2 ]
Iijima, Hiroko [1 ]
Tanaka, Yasuhito [3 ]
Nishiguchi, Shuhei [1 ]
机构：
[1] Hyogo Coll Med, Div Hepatobiliary & Pancreat Dis, Dept Internal Med, Nishinomiya, Hyogo, Japan
[2] Hyogo Coll Med, Dept Microbiol, Nishinomiya, Hyogo, Japan
[3] Nagoya City Univ, Dept Clin Mol Informat Med, Grad Sch Med Sci, Nagoya, Aichi, Japan
来源：
HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：873A / 873A
页数：1
相关论文
共 50 条
  • [1] Pharmacodynamics of interferon-β modulated mRNAs in multiple sclerosis patients with anti-interferon-β neutralizing antibodies
    Ramanathan, M
    Santos, R
    Munschauer, F
    Justinger, T
    Patrick, K
    Weinstock-Guttman, B
    [J]. NEUROLOGY, 2005, 64 (06) : A326 - A327
  • [2] Dynamics of interferon-β-modulated biomarkers in multiple sclerosis patients with persistent anti-interferon-β-neutralizing antibodies
    Weinstock-Guttman, B
    Santos, R
    Munschauer, F
    Justinger, T
    Patrick, K
    Rudick, R
    Ramanathan, M
    [J]. ANNALS OF NEUROLOGY, 2004, 56 : S58 - S58
  • [3] Dynamics of interferon-β modulated mRNA biomarkers in multiple sclerosis patients with anti-interferon-β neutralizing antibodies
    Santos, Roseane
    Weinstock-Guttman, Bianca
    Tamano-Blanco, Miriam
    Badgett, Darlene
    Zivadinov, Robert
    Justinger, Theresa
    Munschauer, Frederick, III
    Ramanathan, Murali
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 2006, 176 (1-2) : 125 - 133
  • [4] Correlation between anti-interferon-β binding and neutralizing antibodies in interferon-β-treated multiple sclerosis patients
    Jensen, P. E. H.
    Sellebjerg, F.
    Sondergaard, H. B.
    Sorensen, P. S.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (10) : 1311 - 1317
  • [5] Neutralizing and binding anti-interferon-β antibodies
    Francis, G
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2001, 8 (06) : 728 - 728
  • [6] Pegylated interferon alpha and anti-interferon neutralizing antibodies development in chronic hepatitis C patients
    Bellomi, F.
    Milella, M.
    Gaeta, G. B.
    Angarano, G.
    Giannelli, G.
    Caporaso, N.
    Scagnolari, C.
    Muto, A.
    Dianzani, F.
    Antonelli, G.
    [J]. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH, 2007, 27 (08): : 733 - 733
  • [7] Treatment with ribavirin and interferon-α reduces interferon-γ expression in patients with chronic hepatitis C
    Bergamini, A
    Bolacchi, F
    Cepparulo, M
    Demin, F
    Uccella, I
    Bongiovanni, B
    Ombres, D
    Angelico, F
    Liuti, A
    Hurtova, M
    Francioso, S
    Carvelli, C
    Cerasari, G
    Angelico, M
    Rocchi, G
    [J]. CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2001, 123 (03): : 459 - 464
  • [8] Treatment of interferon-α for chronic hepatitis C
    Moriyama, Mitsuhiko
    Arakawa, Yasuyuki
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2006, 7 (09) : 1163 - 1179
  • [9] Anti-interferon-α neutralizing antibody induced telaprevir resistance under the interferon-α plus telaprevir treatment in vitro
    Kuga, Chisa
    Enomoto, Hirayuki
    Aizawa, Nobuhiro
    Takashima, Tomoyuki
    Ikeda, Naoto
    Ishii, Akio
    Sakai, Yoshiyuki
    Iwata, Yoshinori
    Tanaka, Hironori
    Saito, Masaki
    Iijma, Hiroko
    Nishiguchi, Shuhei
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 454 (03) : 453 - 458
  • [10] Development and specificities of anti-interferon neutralizing antibodies in patients with chronic hepatitis C treated with pegylated interferon-a
    Scagnolari, C.
    Trombetti, S.
    Solda, A.
    Milella, M.
    Gaeta, G. B.
    Angarano, G.
    Scotto, G.
    Caporaso, N.
    Morisco, F.
    Cozzolongo, R.
    Giannelli, G.
    Fasano, M.
    Santantonio, T.
    Antonelli, G.
    [J]. CLINICAL MICROBIOLOGY AND INFECTION, 2012, 18 (10) : 1033 - 1039
12345